Arkis BioSciences, a leading innovator in minimally invasive surgical instrumentation, has obtained FDA clearance of its new external ventricular drainage catheter, CerebroFlo™. The CerebroFlo catheter has demonstrated a 99% reduction in thrombus accumulation in-vitro, and is indicated for temporary use in patients with elevated intracranial pressure, intraventricular hemorrhage, or hydrocephalic shunt infections. Arkis will debut […]
- Healthcare Professionals
- Healthcare Professionals
Arkis BioSciences News
Arkis is honored to have been chosen as the Top Innovator at the 2017 NY Venture Summit, July 18-19th, 2017. Be sure to visit us in the Big Apple and learn the latest news as Arkis continues to roll out its product portfolio advancing treatments for intracranial hypertension.
Arkis BioSciences exhibits new Subcutaneous GuidewireTM, adding to its minimally invasive product line. Please visit the team now at booth 2047 of the AANS conference in Los Angeles to see the latest additions to the surgical portfolio, and receive an update on our new SureFloTM EVD catheters with Endexo® technology.
Single PassTM shunt workflow enables up to one-third less invasive shunt procedures in hydrocephalus patients. Please see the full press release, or view our Surgical Innovations product site for more information on our minimally invasive Tunneling GuidewireTM.
Arkis BioSciences will be exhibiting at the 2016 Congress of Neurological Surgeons in San Diego, September 24th – 28th. Our innovative product portfolio of neurosurgical devices, including our Tunneling Guidewire, will be available for demonstration. We will also be sharing the company’s plans for the launch of Endexo External Ventricular Drainage catheters. For more information, […]
Arkis BioSciences will be exhibiting at Booth 210 of the 45th annual AANS/CNS Joint Section of Pediatric Sugery, December 5th-8th 2016 in Orlando, FL. Our innovative product portfolio of neurosurgical devices including our Tunneling Guidewire™, Precision Tunneler™and Subcutaneous Guidewire™will be available for demonstration. We will also be sharing the company’s plans for the launch of […]
Come see us at the Nashville Hydrocephalus Association Walk, where people join together to promote a cure for hydrocephalus and to improve the lives of those affected by hydrocephalus! With only 9 days left, the Nashville HA teams have already raised over $17,000 dollars! Arkis BioSciences is proud to be a Bronze sponsor of this […]
Arkis announced this morning the closing of its $3.4 million Series-A investment. The Series-A funding was led by Innova Memphis, followed by Angel Capital Group, the Lighthouse Fund, and other private investors. Arkis’ new financing will accelerate the commercialization of its less-invasive neurosurgical instrumentation and the market release of its in-licensed Endexo® technology.
Learn more about Arkis’ new innovative treatment devices at this year’s Hydrocephalus Association’s National Conference in Minneapolis, June 16 – 19. Arkis is a Bronze sponsor of this year’s 14th annual conference and will be exhibiting at booth 8. To learn more about the Hydrocephalus Association Conference, please visit www.hydrocephalusconference.org.
October 19, 2015: Pershing Yoakley and Associates’ Tom Ballard interviews Arkis’ CEO, Chad Seaver, on the company’s plans for launching its first surgical innovation, the Tunneling GuidewireTM.
Advancing medical technology worldwide to improve the lives of people suffering from intracranial hypertension.
Address: 1 Momentum Way, Knoxville, TN 37920 | Tel: (844) 247-5383 (toll free)
Arkis BioSciences is ISO 13485:2016 certified for its Medical Device Quality Management System by TUV USA, Inc. (Member of TUV NORD Group).